171 related articles for article (PubMed ID: 26903428)
21. Menstrual bleeding patterns in adolescents using etonogestrel (ENG) implant.
Deokar AM; Jackson W; Omar HA
Int J Adolesc Med Health; 2011; 23(1):75-7. PubMed ID: 21721368
[TBL] [Abstract][Full Text] [Related]
22. Twelve-month Continuation of the Etonogestrel Implant in Adolescents With Polycystic Ovary Syndrome.
Buyers E; Sass AE; Severn CD; Pyle L; Cree-Green M
J Pediatr Adolesc Gynecol; 2021 Feb; 34(1):33-39. PubMed ID: 32919086
[TBL] [Abstract][Full Text] [Related]
23. Acceptability of long-acting, progestin-only contraception in Europe: a two-year prospective, non-interventional study.
Short M; Dallay D; Omokanye S; Stauch K; Inki P
Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):29-38. PubMed ID: 24289528
[TBL] [Abstract][Full Text] [Related]
24. Amenorrhea in adolescents using the etonogestrel contraceptive implant.
Tsevat D; Mercier R; Bernheimer C; Lin S; Schwartz B
Contraception; 2024 May; 133():110413. PubMed ID: 38401772
[TBL] [Abstract][Full Text] [Related]
25. Complications and continuation rates associated with 2 types of long-acting contraception.
Berenson AB; Tan A; Hirth JM
Am J Obstet Gynecol; 2015 Jun; 212(6):761.e1-8. PubMed ID: 25555662
[TBL] [Abstract][Full Text] [Related]
26. Best Practices for Counseling Adolescents about the Etonogestrel Implant.
Berlan ED; Richards MJ; Vieira CS; Creinin MD; Kaunitz AM; Fraser IS; Edelman A; Mansour D
J Pediatr Adolesc Gynecol; 2020 Oct; 33(5):448-454. PubMed ID: 32621879
[TBL] [Abstract][Full Text] [Related]
27. Subdermal Contraceptive Implant Insertion Trends and Retention in Adolescents.
Tyson N; Lopez M; Merchant M; Postlethwaite D
J Pediatr Adolesc Gynecol; 2021 Jun; 34(3):348-354. PubMed ID: 33388444
[TBL] [Abstract][Full Text] [Related]
28. Three-year observational study of immediate post-abortion insertion versus menstrual insertion of etonogestrel contraceptive implant.
Zheng W; Tang Y; Wang C; Niu X; Qian Z; Huang L
BMC Womens Health; 2021 Dec; 21(1):436. PubMed ID: 34965871
[TBL] [Abstract][Full Text] [Related]
29. Administration of the etonogestrel contraceptive implant on the day of mifepristone for medical abortion: a pilot study.
Sonalkar S; Hou MY; Borgatta L
Contraception; 2013 Nov; 88(5):671-3. PubMed ID: 24028749
[TBL] [Abstract][Full Text] [Related]
30. Temporal Trends in the Uptake and Continuation of the Etonogestrel Implant in a Large Private Practice Setting.
Howard DL; Ford A; Ceballos S; Volker KW
J Womens Health (Larchmt); 2018 Feb; 27(2):191-195. PubMed ID: 28976797
[TBL] [Abstract][Full Text] [Related]
31. Adolescent experience with intrauterine device insertion and use: a retrospective cohort study.
Bayer LL; Jensen JT; Li H; Nichols MD; Bednarek PH
Contraception; 2012 Nov; 86(5):443-51. PubMed ID: 22560185
[TBL] [Abstract][Full Text] [Related]
32. Etonogestrel implant as a contraceptive choice; patient acceptability and adverse effect profile in a general practice setting.
Riney S; O'Shea B; Forde A
Ir Med J; 2009 Jan; 102(1):24-5. PubMed ID: 19284015
[TBL] [Abstract][Full Text] [Related]
33. Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial.
Hou MY; McNicholas C; Creinin MD
Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):361-6. PubMed ID: 27419258
[TBL] [Abstract][Full Text] [Related]
34. The Etonogestrel Implant in Adolescents: Factors Associated With Removal for Bothersome Bleeding in the First Year After Insertion.
Green S; Sheeder J; Richards M
J Pediatr Adolesc Gynecol; 2021 Dec; 34(6):825-831. PubMed ID: 34089858
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of early discontinuation and associated factors among a retrospective cohort of etonogestrel contraceptive implant users.
Peterson AM; Brown A; Savage A; Dempsey A
Eur J Contracept Reprod Health Care; 2019 Dec; 24(6):475-479. PubMed ID: 31545110
[No Abstract] [Full Text] [Related]
36. Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting.
Tocce K; Sheeder J; Python J; Teal SB
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):59-63. PubMed ID: 22051792
[TBL] [Abstract][Full Text] [Related]
37. Indications for removal of etonogestrel implant within two years of use in Jos, Nigeria.
Mutihir JT; Nyango DD
East Afr Med J; 2010 Nov; 87(11):461-4. PubMed ID: 23457809
[TBL] [Abstract][Full Text] [Related]
38. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
39. Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices.
Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists
Obstet Gynecol; 2012 Oct; 120(4):983-8. PubMed ID: 22996129
[TBL] [Abstract][Full Text] [Related]
40. Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate.
Guazzelli CA; de Queiroz FT; Barbieri M; Torloni MR; de Araujo FF
Contraception; 2010 Sep; 82(3):256-9. PubMed ID: 20705154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
